Double Dream (CBD): A Comprehensive Strain Guide

History and Breeding Origins

Double Dream (CBD) traces its roots to the popularity of the original Double Dream, a sativa-leaning cross that amplified the fruity, elevating character of Blue Dream while adding structure and spice from Dream Star. As consumer interest shifted toward more balanced and CBD-forward experiences in the mid-to-late 2010s, breeders began selecting Double Dream phenotypes with higher cannabidiolic acid (CBDA) expression or outcrossing to established CBD donors. The result is a cultivar that preserves the signature blueberry-citrus bouquet and smooth uplift of its predecessors while significantly moderating intoxication.

Because the name Double Dream refers to a flavor and effect archetype rather than a single proprietary line, multiple breeders have produced CBD-leaning selections under the Double Dream (CBD) label. Common breeding strategies include backcrossing Double Dream to CBD-rich parents such as Cannatonic-type lines or AC/DC, and subsequent filial selection to stabilize a balanced 1:1 to 2:1 CBD:THC ratio. In practice, the CBD variant tends to carry forward Blue Dream’s vigor and Dream Star’s density while shifting chemotype toward higher CBDA output.

The rise of Double Dream (CBD) also reflects a broader market evolution, where balanced flower and extracts gained traction among new and returning consumers. Balanced chemotypes are sought for their gentler learning curve, fewer adverse effects at typical doses, and versatile daytime utility. In many dispensaries, a CBD-forward Double Dream has become a dependable recommendation for patients seeking mood lift without overstimulation.

Given the target strain is specifically Double Dream (CBD), this profile focuses on stabilized, CBD-forward cuts selected for consistency across commercial runs. While cannabinoid ratios vary by breeder and lot, finished lab reports frequently show total cannabinoids above 15% by weight with a CBD fraction equal to or greater than THC. That makes Double Dream (CBD) an approachable yet satisfying option that reads as familiar to Blue Dream fans, but with an intentionally tempered psychoactive ceiling.

Genetic Lineage and Phenotypic Variability

The backbone of Double Dream (CBD) remains the classic Blue Dream lineage, typically Blueberry (DJ Short) x Haze, contributing vigorous growth, berry-sweet terpenes, and a buoyant cerebral lift. Dream Star, often reported as a cross involving Blue Dream and Star Dawg or closely related Chemdawg-descended genetics, adds spice, resin density, and improved branching. Into that framework, CBD donors or selected CBD-dominant phenotypes are introduced, altering enzyme expression in the cannabinoid biosynthetic pathway to favor CBDA alongside or over THCA.

Across seed lines labeled Double Dream (CBD), phenotypic expression splits into two broad chemotypes: balanced 1:1 to 1.5:1 CBD:THC and CBD-dominant 2:1 to 4:1 CBD:THC. Balanced phenotypes often test around 6–10% THC and 7–12% CBD, while CBD-dominant phenotypes may land near 2–5% THC and 8–14% CBD. These ranges reflect environmental variables, harvest timing, and post-harvest stability, but they define the core experience for most growers and consumers.

Morphologically, expect medium-long internodes, flexible stems amenable to training, and a moderate-to-high stretch of 1.6–2.2x after flipping to flower. Dream Star influence can tighten cola structure, mitigating the looser sativa morphology seen in some Blue Dream-dominant plants. CBD selection does not materially change plant architecture, but some CBD-forward phenos display slightly lighter chlorophyll density and marginally broader leaflets in early veg.

Within a single cultivar name, terpene distribution can shift between myrcene-forward berry sweetness and more pinene-limonene citrus-herbal expression. Breeders aiming to preserve the “Double Dream” sensory signature prioritize a blueberry-citrus top note with gentle floral and sandalwood undertones. Uniformity is improved by mother-cut propagation; seed populations will exhibit broader chemotypic spread and may require pheno-hunting to secure the intended CBD ratio.

Visual Appearance and Morphology

Double Dream (CBD) typically forms medium-to-large colas with elongated calyxes that build into tapered spears. The inflorescences are moderately dense—firmer than many hazy sativas, yet not rock-hard—facilitating airflow and manageable dry times. Pistils emerge a pale peach and mature to copper-orange, creating high contrast against a lime-to-forest green backdrop.

Trichome coverage is abundant and glassy, often giving buds a frosted sugar-coating that belies the CBD-heavy nature of the chemotype. Under magnification, glandular heads skew toward mid-sized capitate-stalked trichomes with robust head integrity at harvest, a favorable trait for both flavor retention and mechanical trimming. Sugar leaves can show faint anthocyanin blush in cooler nights—especially from the Blueberry ancestry—leading to lavender highlights in late flower.

In vegetation, plants exhibit hybrid vigor with a strong apical drive and long lateral branches that respond well to topping and low-stress training. Internodal spacing ranges from 3–6 cm under high PPFD and appropriate blue light fraction, expanding under lower light intensity. Stems are pliant yet resilient, and silica supplementation at 50–100 ppm typically produces sturdy scaffolding without brittleness.

Final height indoors tends to fall between 120–180 cm in a 7–10 week flower program, depending on veg duration and training. Outdoor plants can exceed 200–250 cm with adequate root volume (e.g., 50–100 L fabric pots) and full-sun exposure. Yield potential is competitive, with properly dialed runs producing sizable, shapely colas that trim efficiently while preserving bag appeal.

Aroma and Bouquet

On first encounter, Double Dream (CBD) presents a layered bouquet dominated by sweet blueberry and candied citrus peel. Lighter floral tones—often violet and lavender-adjacent—float above a faint sandalwood base, while a hint of herbal freshness suggests pinene and ocimene. Grinding the flower intensifies berry jam notes and releases a subtle peppery sparkle associated with caryophyllene.

As the buds warm during handling, a more complex undercurrent emerges, blending sweet cream, faint eucalyptus, and a mild green tea edge. This evolving aroma reflects a terpene matrix typically anchored by myrcene, limonene, beta-pinene, and beta-caryophyllene, with meaningful contributions from linalool and ocimene. In aroma chamber tests, total volatile load often sits in the 1.5–3.0% range by dry weight, ample for a pronounced nose without overwhelming pungency.

Compared to the original Double Dream, the CBD variant’s bouquet trends slightly cleaner and less aggressively hazy. The higher CBD fraction does not directly change terpene synthesis, but breeder selection for approachable daytime appeal often favors brighter citrus-floral top notes over diesel-funk. That makes the aromatic profile inviting for newer consumers who may be sensitive to sharp, gassy aromatics.

Cured properly, the bouquet remains stable for 6–8 weeks in sealed containers stored at 60–62% relative humidity and 16–20°C. Beyond that window, oxidative changes slowly mute the citrus and berry peaks, leaning the aroma toward woody and tea-like tones. Vacuum-sealed storage and protection from UV can significantly extend aromatic fidelity.

Flavor and Palate

The inhale opens with ripe blueberry, light vanilla cream, and a citrus zest that lands between sweet orange and Meyer lemon. Vaporization at 175–190°C preserves delicate terpenoids and delivers a clean, almost confectionary sweetness with a floral lift. Combustion introduces a barely-there toastiness while keeping the finish smooth if the cure is slow and complete.

Mid-palate, a soft herbal quality emerges—think fresh rosemary tips and spearmint—with a peppery flicker on the exhale. That pepper-green interplay points to beta-caryophyllene and pinene, while linalool contributes a round, perfumed softness. Extractions or rosin pressed at 80–90°C for 60–120 seconds maintain high terpene fidelity and a syrupy berry-citrus profile.

Mouthfeel is medium-bodied and lightly resinous, leaving a gentle sweetness without cloying aftertaste. Terpene persistence is notable for 1–3 minutes post-exhale, with the citrus component fading first and the woody-floral backbone lingering. Water-cured or over-dried samples can taste flattened, confirming the importance of a 10–14 day slow dry and a 3–6 week cure for optimal flavor development.

In blind tastings, many users identify the flavor lineage as related to Blue Dream, but with clearer citrus definition and less haze-influenced sharpness. Palates sensitive to bitterness will appreciate the restrained pith and minimal astringency even at higher temperatures. Overall, Double Dream (CBD) is a versatile flavor profile that performs well in flower, pre-rolls, and low-temp concentrates.

Cannabinoid Profile and Ratios

Double Dream (CBD) is defined by its balanced to CBD-dominant cannabinoid ratios. Verified lab results from stabilized phenotypes commonly fall within 6–10% Δ9-THC and 7–12% CBD for 1:1 to 1.5:1 lines. CBD-forward selections often test at 2–5% THC and 8–14% CBD, suitable for consumers seeking function-forward relief with minimal intoxication.

Total cannabinoids typically range from 15–22% by dry weight when grown under optimized conditions and harvested at peak ripeness. Minor cannabinoids appear in trace-to-low quantities: cannabigerol (CBG) often registers 0.3–1.0%, cannabichromene (CBC) 0.2–0.8%, and tetrahydrocannabivarin (THCV) occasionally at 0.1–0.3% in certain Dream Star-leaning cuts. While these minors are present at modest levels, they may contribute to entourage effects and subjective nuance.

For dosing context, one gram of flower at 8% THC and 10% CBD contains approximately 80 mg THC and 100 mg CBD. A typical 0.25 g session would deliver roughly 20 mg THC and 25 mg CBD, though bioavailability varies by route of administration (inhaled THC ~20–35%; inhaled CBD ~10–20%). Users seeking milder effects can halve that dose, as many report functional, clear-headed outcomes in the 5–10 mg THC with matching or higher CBD range.

Harvest timing can subtly shift the ratio: earlier harvests (day 56–60 of flower) can favor slightly higher CBDA relative to THCA in some phenotypes, while late harvests (day 63–70) may increase total THCA and oxidized byproducts. Post-harvest stability also matters; prolonged exposure to heat, oxygen, and light can degrade cannabinoids, with potential THC to CBN conversion that alters effect quality. Vacuum sealing, cool storage, and tight cure parameters help preserve the intended profile for several months.

Terpene Profile and Chemical Aroma Drivers

The dominant terpene in many Double Dream (CBD) cuts is beta-myrcene, commonly testing at 0.4–0.8% by weight and shaping the ripe berry and soft herbal baseline. Limonene frequently follows at 0.3–0.6%, imparting sweet citrus zest and a mood-brightening sparkle. Beta-pinene and alpha-pinene together often contribute 0.2–0.5%, adding pine-herb lift and helping keep the bouquet airy rather than heavy.

Beta-caryophyllene commonly registers at 0.2–0.5% and brings a warm pepper note; pharmacologically, it is a CB2 receptor agonist that may influence perceived inflammation modulation. Linalool in the 0.1–0.3% range adds florals reminiscent of lavender and violet, smoothing the edges of the brighter terpenes. Ocimene and terpinolene are intermittent but welcome guests, together ranging 0.1–0.3% in many phenotypes, nudging the profile toward candy-sweet and slightly effervescent.

Total terpene concentration for quality, slow-cured flower typically lands between 1.5–3.0% by weight. This is sufficient to drive a vivid sensory experience while maintaining stability through a standard 10–14 day dry and multi-week cure. Samples cured above 65% RH risk terpene volatilization and microbial growth, while sub-55% RH can hamper terpene release on consumption.

From a formulation perspective, the terpene balance explains the cultivar’s friendly daytime reputation. Myrcene grounds the profile without overly sedating, limonene and pinene brighten mood and attention, and caryophyllene provides a gentle, warm backbone. The ensemble effect aligns well with a CBD-forward cannabinoid matrix, supporting calm focus rather than couchlock.

Experiential Effects and Onset

Double Dream (CBD) is widely described as clear-headed, buoyant, and steady, delivering uplift without the sharp spikes that can accompany high-THC sativas. Early effects are often felt as easing tension in the shoulders and face, a leveled mood, and a gentle nudge toward focus. Many users report improved task engagement and social ease within 5–10 minutes of inhalation.

Compared to THC-dominant Blue Dream lines, the CBD variant tempers intensity and reduces the likelihood of racing thoughts or jitters. CBD’s modulatory action at various receptor targets and its indirect influence on THC’s CB1 binding can soften peak intoxication. In practical terms, the result is a gliding ascent and a wider comfortable dosing window for novice or sensitive users.

Onset via inhalation typically occurs within 2–5 minutes, reaches peak in 15–30 minutes, and tapers over 2–4 hours depending on dose and user tolerance. Edible or tincture formats extend the timeline: onset at 30–90 minutes, peak at 2–3 hours, and a 4–6 hour tail. Balanced ratios tend to produce fewer adverse effects like paranoia or tachycardia at equivalent THC doses, though individual responses vary.

Functionally, Double Dream (CBD) fits well for daytime activities, creative work, and low-intensity exercise. The combination of limonene/pinene brightness and CBD’s calming influence lends itself to steady concentration and sociability. At higher doses, some users note a gentle body heaviness and a warm, relaxed finish without full sedation.

Potential Therapeutic and Medical Applications

While no cannabis cultivar can be universally therapeutic, the CBD-leaning chemistry of Double Dream (CBD) aligns with several commonly reported use cases. Balanced ratios are frequently chosen for stress modulation, situational anxiety, and mood support due to CBD’s anxiolytic potential in specific contexts. Users sensitive to THC’s psychoactivity may find the 1:1 to 2:1 CBD:THC range more tolerable while still benefiting from THC’s analgesic and anti-spasmodic properties.

Anecdotally, patients reach for Double Dream (CBD) in cases of tension-type headaches, low-to-moderate musculoskeletal pain, and post-exertional soreness. The caryophyllene content may contribute to perceived relief via CB2 receptor activity, and myrcene can complement body comfort without heavy sedation at typical doses. Inhalation allows for titration in small increments (e.g., 1–2 inhalations delivering roughly 2–5 mg THC and 3–6 mg CBD) to find a functional baseline.

For sleep-adjacent concerns, the cultivar is more supportive of wind-down than outright sedation in most users. Those seeking nighttime applications often pair flower with a modest dose of CBN-containing products or extend the dose slightly to lean on myrcene’s body-calming effects. Conversely, daytime users commonly prefer microdoses in the 2–4 mg THC and 3–8 mg CBD range to avoid afternoon sluggishness.

It is important to note that individual responses to cannabinoids vary with genetics, prior exposure, and concurrent medications. Anyone considering cannabis for medical purposes should consult a qualified clinician, particularly when managing chronic conditions or using pharmaceuticals with potential CYP450 interactions. Data-driven experimentation—starting low, going slow, and keeping notes—can help identify whether Double Dream (CBD) aligns with personal therapeutic goals.

Cultivation Guide: From Seed to Cure

Double Dream (CBD) rewards growers who favor clean canopies, environmental con